Link to: Get in touch
Indicator 1
Essential list of Medicines for NCDs at the PHC level
Indicator
The essential list of Medicines for NCDs at the PHC level:
- a. established and adopted
- b. operational
Presence or Absence
Present
Definition
15 Essential Medicines List from CCS (Insulin, Aspirin, Metformin, Thiazides (Direutics), ACE Inhibitors, ARBs,CCBs, Beta Blockers, Statins, Oral Morphine, Steroid Inhaler, Bronchodilator, Sulphonyureas, Benzathine Penicillin Injection, Nicotine Replacement Therapy)
Reference
Indicator 2
List of Essential NCD technologies including standard priority diagnostics and equipment
Indicator
List of Essential NCD technologies including standard priority diagnostics and equipment:
- a. established and adopted
- b. operational
Presence or Absence
Present
Definition
12 Basic Technologies from CCS ( Weight, Height, Blood Glucose, OGT Test, HbA1c test, Dilated Fundus, Foot Vibration, Urine strip for glucose and ketone, Blood Pressure, Total Cholesterol, Urine Strips for albumin assay, Spirometry)
Reference
Indicator 3
% of PHC facilities with NCD EML correlated to package of services delivered in PHC
Indicator
% of PHC facilities with NCD EML correlated to a package of services delivered in PHC
Presence or Absence
Present
Definition
Numerator: Number of PHC facilities with PHC EML list correlated to a package of services delivered in PHC
Denominator: Total number PHC facilities
Reference
SIB, NAB, SINA & PARSA electronic health record systems
Raw Data
wdt_ID | Disaggregation | Numerator | Denumerator | Percent |
---|---|---|---|---|
1 | Country | 5,991 | 5,991 | 100.0 |
2 | Urban | 3,202 | 3,202 | 100.0 |
3 | Rural | 2,789 | 2,789 | 100.0 |
*Our list consists of Insulin, Aspirin, Metformin, Thiazides ( Diuretics), ACE Inhibitors, ARBs, CCBs, Beta Blockers, Statins, Sulphonyureas, and Benzathine Penicillin Injection
Indicator 4
% PHC facilities with a list of Essential NCD technologies including standard priority diagnostics and equipment
Indicator
% PHC facilities with a list of Essential NCD technologies including standard priority diagnostics and equipment
Presence or Absence
Present
Definition
Numerator: Number of primary care facilities with standard priority diagnostics and equipment available for NCDs according to national standards
Denominator: Total number PHC facilities
Reference
SIB, NAB, SINA & PARSA electronic health record systems
Raw Data
wdt_ID | Disaggregation | Numerator | Denumerator | Percent |
---|---|---|---|---|
1 | Country | 5,991 | 5,991 | 100.0 |
2 | Urban | 3,202 | 3,202 | 100.0 |
3 | Rural | 2,789 | 2,789 | 100.0 |
*The basic NCD technologies of HbA1c test, Dilated Fundus, Foot Vibration, and Urine strip for glucose and ketone, Urine Strips for albumin assay, and Spirometry are available in about 10 % of the PHC facilities. The rest items on the list are available in all PHC facilities.
Indicator 5
% of PHC facilities with functional essential technologies for early detection, diagnosis, and monitoring of NCDs are available (the public and private health sector)
Indicator
% of PHC facilities with functional essential technologies for early detection, diagnosis, and monitoring of NCDs are available (the public and private health sector)
Presence or Absence
Present
Definition
Numerator: Number of PHC facilities with functional essential technologies for early detection, diagnosis, and monitoring of NCDs are available
Denominator: Total number PHC facilities
Reference
SIB, NAB, SINA & PARSA electronic health record systems
Raw Data
wdt_ID | Disaggregation | Numerator | Denumerator | Percent |
---|---|---|---|---|
1 | Country | 5,991 | 5,991 | 100.0 |
* All PHC facilities are equipped with these technologies and use them informally, but they are officially used in 210 (4%) PHC facilities where the full package of NCD is implemented.
Indicator 6
Availability and affordability of NCD medicines in Public/private sector
Indicator
Availability and affordability of NCD medicines in Public/private sector
Presence or Absence
Present
Reference
- Heidari E, Varmaghani M, Abdollahiasl A. Availability, pricing and affordability of selected medicines for noncommunicable diseases. East Mediterr Health J. 2019 Oct 4;25(7):473-480. DOI: 10.26719/emhj.18.068. PMID: 31612979.
- Report on prevention and control non-communicable diseases (Chapter 5 especially page 97)